1. Home
  2. SNDX vs BANR Comparison

SNDX vs BANR Comparison

Compare SNDX & BANR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • BANR
  • Stock Information
  • Founded
  • SNDX 2005
  • BANR 1890
  • Country
  • SNDX United States
  • BANR United States
  • Employees
  • SNDX N/A
  • BANR N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • BANR Major Banks
  • Sector
  • SNDX Health Care
  • BANR Finance
  • Exchange
  • SNDX Nasdaq
  • BANR Nasdaq
  • Market Cap
  • SNDX 1.7B
  • BANR 2.1B
  • IPO Year
  • SNDX 2016
  • BANR 1995
  • Fundamental
  • Price
  • SNDX $19.89
  • BANR $67.93
  • Analyst Decision
  • SNDX Strong Buy
  • BANR Buy
  • Analyst Count
  • SNDX 9
  • BANR 6
  • Target Price
  • SNDX $35.78
  • BANR $56.80
  • AVG Volume (30 Days)
  • SNDX 911.4K
  • BANR 286.9K
  • Earning Date
  • SNDX 10-31-2024
  • BANR 10-16-2024
  • Dividend Yield
  • SNDX N/A
  • BANR 2.83%
  • EPS Growth
  • SNDX N/A
  • BANR N/A
  • EPS
  • SNDX N/A
  • BANR 4.78
  • Revenue
  • SNDX $3,500,000.00
  • BANR $593,391,000.00
  • Revenue This Year
  • SNDX N/A
  • BANR N/A
  • Revenue Next Year
  • SNDX $247.63
  • BANR $5.27
  • P/E Ratio
  • SNDX N/A
  • BANR $14.21
  • Revenue Growth
  • SNDX N/A
  • BANR N/A
  • 52 Week Low
  • SNDX $11.22
  • BANR $39.31
  • 52 Week High
  • SNDX $25.34
  • BANR $68.11
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 58.19
  • BANR 79.45
  • Support Level
  • SNDX $17.83
  • BANR $62.61
  • Resistance Level
  • SNDX $20.24
  • BANR $60.01
  • Average True Range (ATR)
  • SNDX 0.71
  • BANR 1.69
  • MACD
  • SNDX 0.21
  • BANR 0.80
  • Stochastic Oscillator
  • SNDX 85.51
  • BANR 98.40

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About BANR Banner Corporation

Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.

Share on Social Networks: